InnoMedica is a young nanotech company with around 40 employees, several promising drugs in preclinical and clinical development and its own clean room production. The pipeline is based on a liposomal delivery system and includes, in particular, parenteral drug candidates applied in neurology (a new approach to treat Parkinson's disease) and oncology (chemotherapy).
Key information
- 21 - 50 employees
- Route Ancienne Papeterie, 1723 Marly
- InnoMedica Schweiz AG